Amanote Research
Register
Sign In
Figure 2: Prevalence of HIV Drug Resistance to NRTI (A), NNRTI (B), and PI (C) Classes Between 2006 and 2016.
doi 10.7717/peerj.4848/fig-2
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Prevalence of Transmitted HIV Drug Resistance in Iran Between 2010 and 2011
PLoS ONE
Multidisciplinary
Differential Drug Resistance Acquisition in HIV-1 of Subtypes B and C
PLoS ONE
Multidisciplinary
Comparison of the Mechanisms of Drug Resistance Among HIV, Hepatitis B, and Hepatitis C
Viruses
Virology
Infectious Diseases
Figure 2: A Proportional Comparison of Most Abundant Classes Between the ImProm-II at 42 and 55 °C (A) and the ImProm-II at 55 °C and SuperScriptIV at 55 °C (B).
Prevalence and Evolution of Drug Resistance HIV-1 Variants in Henan, China
Cell Research
Cell Biology
Molecular Biology
High Prevalence of HIV-1 Intersubtype B′/C Recombinants Among Injecting Drug Users in Dehong, China
PLoS ONE
Multidisciplinary
HIV-2 Treatment in Mali and Drug Resistance Antiretroviral Profile
International STD Research & Reviews
HIV-1 Molecular Characterization and Transmitted Drug Resistance Prevalence Among Treatment-Naïve Individuals
Journal of AIDS and HIV Infections
HIV Encephalopathy Due to Drug Resistance Despite 2-Year Suppression of HIV Viremia by cART
Clinical Neurology
Neurology
